glp 1 agonist retatrutide Some Providers Prescribe Unapproved for Weight Loss at Alarming Rate 🚨 Retatrutide TRIUMPH-1 Phase 3

Dosage: 200-500 mcg, 1-2 times daily via subcutaneous injection or daily oral capsules

Participants self-injected themselves with placebo for 4 weeks followed by a 16-week administration of a GHRH analog

Compare this to subcutaneous injection at 80-95% bioavailability

But what about bioavailability

Its like your body getting VIP access to all the antioxidant action it needs, stat

[1] [4] Missing doses may potentially lead to: Changes in appetite and satiety Temporary weight management challenges Possible gastrointestinal effects when resuming treatment Delayed achievement of weight loss goals To minimize missed doses, consider setting a weekly reminder on your phone, using a medication tracking app, or coordinating your injection with a regular weekly activity